These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19794357)

  • 1. Psychotic disorders and comorbidity: somatic illness vs. side effect.
    Kozumplik O; Uzun S; Jakovljević M
    Psychiatr Danub; 2009 Sep; 21(3):361-7. PubMed ID: 19794357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive disorders and comorbidity: somatic illness vs. side effect.
    Uzun S; Kozumplik O; Topić R; Jakovljević M
    Psychiatr Danub; 2009 Sep; 21(3):391-8. PubMed ID: 19794363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome in patients with psychotic disorders: diagnostic issues, comorbidity and side effects of antipsychotics.
    Kozumplik O; Uzun S; Jakovljević M
    Psychiatr Danub; 2010 Mar; 22(1):69-74. PubMed ID: 20305594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychofarmacology in the prevention of somatic comorbid diseases in mentally ill patients.
    Jukić V; Petrović Z; Brecić P; Krizaj A; Savić A; Baceković A; Bilić P; Susac J; Mandić A; Prazen I
    Psychiatr Danub; 2009 Sep; 21(3):350-5. PubMed ID: 19794355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in values of cholesterol and tryglicerides after weight loss during treatment with aripiprazole in a patient with schizophrenia - Case report.
    Uzun S; Kozumplik O; Sedić B
    Psychiatr Danub; 2010 Jun; 22(2):373-6. PubMed ID: 20562787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comorbidity of diabetes mellitus and psychiatric disorders.
    Medved V; Jovanović N; Knapić VP
    Psychiatr Danub; 2009 Dec; 21(4):585-8. PubMed ID: 19935498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects of antipsychotics in the elderly.
    Masand PS
    J Clin Psychiatry; 2000; 61 Suppl 8():43-9; discussion 50-1. PubMed ID: 10811243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health management of older persons with chronically medicated psychotic disorders: the results of a survey in France.
    Arbus C; Clement JP; Bougerol T; Fremont P; Lancrenon S; Camus V
    Int Psychogeriatr; 2012 Mar; 24(3):496-502. PubMed ID: 21835072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses.
    Newcomer JW
    J Clin Psychiatry; 2009; 70 Suppl 3():30-6. PubMed ID: 19570499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Higher mortality and somatic illness in a psychotic diseases].
    Lindh Å; Gothefors D; Runeson B
    Lakartidningen; 2015 Oct; 112():. PubMed ID: 26461503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy for aggressive behaviours in persons with intellectual disabilities: treatment or mistreatment?
    Tsiouris JA
    J Intellect Disabil Res; 2010 Jan; 54(1):1-16. PubMed ID: 20122096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha-interferon and mental disorders].
    Debien C; De Chouly De Lenclave MB; Foutrein P; Bailly D
    Encephale; 2001; 27(4):308-17. PubMed ID: 11686052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.
    Meltzer HY; Davidson M; Glassman AH; Vieweg WV
    J Clin Psychiatry; 2002; 63 Suppl 9():25-9. PubMed ID: 12088173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical illness in patients with schizophrenia.
    Goldman LS
    J Clin Psychiatry; 1999; 60 Suppl 21():10-5. PubMed ID: 10548136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.